BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The proceeds will be used to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Proposed Public Offering
BioSig intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be used to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions, with uncertainties regarding timing, size, and terms.
- Investors are advised to read the preliminary prospectus supplement and other SEC filings for complete information before investing.
The announcement of the proposed public offering by BioSig Technologies Inc. marks a strategic move to raise capital for investment and corporate purposes.